Chien Fu Hung
Chang Gung University
3 Papers
Chien Fu Hung is an academic researcher from Chang Gung University. The author has contributed to research in topics: Internal medicine & Hepatocellular carcinoma. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow,Mihir Gandhi,Say Beng Tan,Maung Win Khin,Ariunaa Khasbazar,Janus P. Ong,Su Pin Choo,Peng Chung Cheow,Chanisa Chotipanich,Kieron Lim,Laurentius A. Lesmana,Tjakra Manuaba,Boon Koon Yoong,Aloysius Raj,Chiong Soon Law,Ian Homer Y. Cua,Rolley Rey Lobo,Catherine Teh,Yun Hwan Kim,Yun Won Jong,Ho-Seong Han,Si Hyun Bae,Hyun-Ki Yoon,Rheun Chuan Lee,Chien Fu Hung,Cheng Yuan Peng,Po-Chin Liang,Adam Bartlett,Kenneth Y.Y. Kok,Choon Hua Thng,Albert S. C. Low,Anthony S. W. Goh,Kiang Hiong Tay,Richard Hoau Gong Lo,Brian K. P. Goh,David Chee Eng Ng,Ganesh Lekurwale,Wei Ming Liew,Val Gebski,Kenneth Seck Wai Mak,Khee Chee Soo +40 more
TL;DR: In patients with locally advanced HCC, OS did not differ significantly between RE and sorafenib, and the improved toxicity profile of RE may inform treatment choice in selected patients.
568
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019
Kwong-Ming Kee,Chien-Hung Chen,Jui‐Ting Hu,Yi-Hsiang Huang,Tsang-En Wang,Gar-Yang Chau,Kuo-Hsin Chen,Yao-Li Chen,Chih-Che Lin,Chien Fu Hung,Shiu Feng Huang,Tsang Wu Liu,Hsiu Ying Ku,Bing-Shen Huang,Yi-Pin Wang,Hui Ping Tseng,Chun-Ju Chiang,Sheng Nan Lu +17 more
TL;DR: In this paper , the authors investigated the trend of characteristics and the survival of HCC in recent decades after making increased efforts and found that the overall male-to-female ratio was 7/3.
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
Pi-yi Chang,Rheun Chuan Lee,Po-Chin Liang,Yisheng Liu,Yu Cheng,Jen-I Huang,Hsiuo-Shan Tseng,Chien Fu Hung,Reng-Hong Wu,Ming-Chih Chern,Hua-Ming Cheng,Chih-Horng Wu,Sheila Cheng,Chia-Ling Chiang,Huei-Lung Liang +14 more
TL;DR: In this paper , a panel of experts specializing in different aspects of hepatocellular carcinoma (HCC) treatment was formed to devise modernized recommendations that reflect recent clinical experiences, as well as cTACE protocols which are tailored for use in Taiwan.